Form4insider filings, from the source

SEC Form 4 · accession 0001209191-19-005422

IRONWOOD PHARMACEUTICALS INC · IRWD

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Peter M Hecht
Officer — Chief Executive Officer · Director
Period of report
Jan 23, 2019
Accepted (ET)
Jan 25, 2019 · 6:24 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001446847

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Class A Common StockJan 23, 2019M30,000$4.89A4,726,917D
Class A Common StockF2Jan 23, 2019S30,000$12.66D4,696,917D
Class A Common StockJan 24, 2019M30,000$4.89A4,726,917D
Class A Common StockF3Jan 24, 2019S30,000$12.70D4,696,917D
Class A Common StockJan 25, 2019M29,551$4.89A4,726,468D
Class A Common StockF4Jan 25, 2019S29,551$12.23D4,696,917D
Class A Common StockJan 25, 2019M20,449$4.89A4,717,366D
Class A Common StockF5holding———4,850IThe 2000 Trust for Alexis Mae Hecht
Class A Common StockF5holding———4,850IThe 2000 Trust for Malcolm Paul Hecht
Class A Common StockF5holding———4,850IThe 2000 Trust for Zoe Niovi Hecht

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
Employee Stock Option (Right to Buy)F6$4.89Jan 23, 2019M30,000D—Feb 11, 2019Class A Common Stock30,00080,000D
Employee Stock Option (Right to Buy)F6$4.89Jan 24, 2019M30,000D—Feb 11, 2019Class A Common Stock30,00050,000D
Employee Stock Option (Right to Buy)F6$4.89Jan 25, 2019M29,551D—Feb 11, 2019Class A Common Stock29,55120,449D
Employee Stock Option (Right to Buy)F6$4.89Jan 25, 2019M20,449D—Feb 11, 2019Class A Common Stock20,4490D

Explanation of responses